Since ZRF1 knockdown MCF7 cells exhibited such a robust phenotype after TAM treatment, we investigated their response towards pure anti-estrogen ICI 182,780 (ICI), which is used for the treatment of Tamoxifen resistant breast cancer tumors in the clinic. This evidence concerns the gene DNAJC2 and breast carcinoma.